Vandetanib in a Child Affected by Neurofibromatosis Type 1 and Medullary Thyroid Carcinoma with Both NF1 and Homozygous RET Proto-oncogen Germ-line Mutations.
- DOI
- 10.4274/jcrpe.galenos.2020.2020.0051
- Published
- 2021 Aug 23
- Container
- Journal of clinical research in pediatric endocrinology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.4274/jcrpe.galenos.2020.2020.0051,
title = {Vandetanib in a Child Affected by Neurofibromatosis Type 1 and Medullary Thyroid Carcinoma with Both NF1 and Homozygous RET Proto-oncogen Germ-line Mutations.},
author = {Demir Gündoğan B and Sağcan F and Tuğ Bozdoğan S and Balcı Y and Tuncel Daloğlu F and Çağlar Çıtak E},
year = {2021},
journal = {Journal of clinical research in pediatric endocrinology},
doi = {10.4274/jcrpe.galenos.2020.2020.0051},
url = {https://doi.org/10.4274/jcrpe.galenos.2020.2020.0051}
}RIS
TY - JOUR TI - Vandetanib in a Child Affected by Neurofibromatosis Type 1 and Medullary Thyroid Carcinoma with Both NF1 and Homozygous RET Proto-oncogen Germ-line Mutations. AU - Demir Gündoğan B AU - Sağcan F AU - Tuğ Bozdoğan S AU - Balcı Y AU - Tuncel Daloğlu F AU - Çağlar Çıtak E PY - 2021 JO - Journal of clinical research in pediatric endocrinology DO - 10.4274/jcrpe.galenos.2020.2020.0051 UR - https://doi.org/10.4274/jcrpe.galenos.2020.2020.0051 ER -
APA
B, D. G., F, S., S, T. B., Y, B., F, T. D., & E, Ç. Ç. (2021). Vandetanib in a Child Affected by Neurofibromatosis Type 1 and Medullary Thyroid Carcinoma with Both NF1 and Homozygous RET Proto-oncogen Germ-line Mutations.. Journal of clinical research in pediatric endocrinology. https://doi.org/10.4274/jcrpe.galenos.2020.2020.0051
Source records
- pubmed · retrieved 2026-09-25T18:51:54.586Z